Short answer
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) filed an 8-K current report with the SEC on March 6, 2026 reporting Item 7.01 (Regulation FD Disclosure). Clover Health published supplemental Q&A on Mar 6, 2026 addressing investor questions from Q4 2025 earnings.
CLOVER HEALTH INVESTMENTS, CORP. /DE 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Clover Health published supplemental Q&A on Mar 6, 2026 addressing investor questions from Q4 2025 earnings
- Content targets shareholder engagement beyond standard earnings disclosure: signal of active investor relations effort
- Full responses in Exhibit 99.1; key financial/operational details would be contained there
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CLOVER HEALTH INVESTMENTS, CORP. /DE 8-K filings
Get the next CLOV 8-K as it lands
Follow CLOV for push alerts, or ask the research agent what this filing means.